T&L Co., LTD.

340570 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩27,800.00
-0.89%
Delayed · cached 15 min

Fair value analysis

340570
T&L Co., LTD.
PharmaceuticalsPharmaceuticals
₩27,800.00
Close used for this calculation
₩76,097.91Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
96/100
Profitability25/25
Returns21/25
Balance Sheet25/25
Efficiency25/25
Growth25/25
Exceptional
Quality radar
96Prof.25/25Ret.21/25Eff.25/25B.Sht25/25Growth25/25

Consensus fair value

₩76,097.91
Below FV
▲ +173.7% against the close used
Model range ₩46,537.20 – ₩307,114.29
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩46,537.20Fair value₩76,097.91Bull₩307,114.29
FairClose
52-week traded range
52W low ₩21,775.0052W high ₩33,500.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

T&L Co., LTD. closed at ₩27,800.00, 63.5% below the consensus fair value of ₩76,097.91 drawn from 10 valuation models.

Financial DNA score 96/100 — Exceptional. P/E of 5.9x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩49,776.86
+79.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩51,732.32
+86.1%
√(22.5 × EPS × BVPS)
EPS=4749.19, BVPS=25045.05
Graham Formula
₩307,114.29
+1,004.7%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=20%, FD=3.3%
P/E Fair Value
₩94,983.80
+241.7%
EPS × 20x (sector P/E)
EPS=4749.19, Sector P/E=20x
Peter Lynch (PEG)
₩142,475.70
+412.5%
EPS × Growth% (PEG = 1 is fair)
EPS=4749.19, g=30%
EV/EBITDA
₩104,066.38
+274.3%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=46.35B
Dividend Discount (DDM)
₩46,537.20
+67.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=861.8, r=10%, g=8%
Book Value (P/B)
₩80,958.11
+191.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=25045.05, ROE=18.9%, g=6%, r=10%
Reverse DCF
₩27,800.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -10% | Historical: 30.6%
Margin of Safety
₩94,426.36
+239.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=125901.82, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.